Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as a transformative treatment for weight management, with clinical trials showing average weight loss of 15 percent at the 1 mg dose and up to 22 percent at the 2.4 mg dose. However, the right dose for you depends on your unique metabolic profile, baseline health status, and genetic factors. PlexusDx helps patients understand their personalized dosing needs through precision health testing and compounded medication access.

What Constitutes a Normal Semaglutide Dose Range

Semaglutide dosing typically begins at 0.25 mg once weekly, with gradual increases every four weeks to minimize gastrointestinal side effects. Most patients reach therapeutic benefit between 1 mg and 2.4 mg weekly, though some individuals respond effectively at lower maintenance doses. The standard escalation protocol moves from 0.25 mg to 0.5 mg to 1 mg to 1.5 mg to 2 mg, with 2.4 mg as the maximum approved dose for weight management.

Your individual dose requirement reflects how your body processes GLP-1 receptor signaling and metabolizes glucose. Factors including age, kidney function, concurrent medications, and baseline weight all influence the optimal starting point and escalation speed. PlexusDx compounded semaglutide begins at $149 per month, and your dose may need to increase over time—but your price won't, ensuring predictable costs throughout your treatment journey.

How Genetic Testing Reveals Your Semaglutide Response Potential

The Precision Peptide Genetic Test from PlexusDx identifies variations in key genes that regulate GLP-1 receptor function, appetite control, and metabolic rate. Specific genetic variants like GLP1R rs6923761 and GIPR rs1800437 directly influence how effectively your body responds to semaglutide stimulation. Understanding these pathways helps predict whether you'll achieve meaningful weight loss at standard doses or may benefit from combination therapy or higher escalation.

PlexusDx maps 14 distinct metabolic pathways across 49 peptides, generating 150+ personalized genetic insights that extend far beyond simple drug response predictions. The $99 add-on genetic test (available after your first month of treatment) reveals whether your FTO gene variant rs9939609 increases appetite drive, helping your clinical team calibrate behavioral support alongside medication. This precision approach explains why two patients on identical semaglutide doses experience dramatically different outcomes.

Comparing Individual Dose Needs: Why One Size Doesn't Fit All

Clinical observation shows that roughly 30 percent of semaglutide patients achieve optimal weight loss at doses below 1 mg weekly, while 40 percent require 1.5 mg to 2 mg, and the remaining 30 percent benefit from the maximum 2.4 mg dose. This distribution reflects genuine biological variation in GLP-1 pathway sensitivity rather than treatment failure. Genetic factors explain a substantial portion of this variation, making personalized testing a logical step before committing to long-term therapy.

Patients with genetic predispositions toward insulin resistance may require higher doses to achieve sufficient appetite suppression and metabolic improvement. Conversely, individuals with heightened GLP-1 receptor sensitivity sometimes experience excellent results at microdose protocols, which PlexusDx offers at just $129 per month for those seeking a gentler introduction. Starting with genetic insight allows your healthcare provider to design a dosing strategy aligned with your specific biology rather than trial-and-error escalation.

PlexusDx Compounded Semaglutide: Access and Affordability Without Surprises

PlexusDx partners exclusively with licensed 503A compounding pharmacies to deliver pharmaceutical-grade semaglutide across all 50 states without insurance requirements or membership fees. Compounded semaglutide injections start at $149 per month across all commitment tiers, with no increase as your dose escalates—directly addressing the cost burden that makes branded semaglutide inaccessible for many patients. HSA and FSA accounts cover PlexusDx medications, further reducing out-of-pocket expense.

Oral semaglutide options through PlexusDx start at $249 monthly for patients preferring non-injectable delivery, though injection formulations typically demonstrate superior bioavailability and weight loss outcomes. Your first month of treatment establishes baseline response before adding the Precision Peptide Genetic Test, allowing you to make informed decisions about dose adjustments and combination therapy with complete genetic context. This sequenced approach maximizes clinical value while maintaining affordability and transparency.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What semaglutide dose should I expect to start at?

Standard initiation begins at 0.25 mg weekly, increasing by 0.25 mg every four weeks until you reach therapeutic benefit or your target dose. Most patients stabilize between 1 mg and 2.4 mg, though PlexusDx genetic testing can predict your likely optimal range before escalation begins. Starting dose depends on your baseline health, kidney function, and prior medication tolerance.

How much weight loss should I expect at different semaglutide doses?

Clinical trials show approximately 7 percent weight loss at the 0.5 mg dose, 12 percent at 1 mg, 18 percent at 1.5 mg, and 22 percent at 2.4 mg over 68 weeks. Your individual results vary based on genetic factors, dietary adherence, activity level, and baseline metabolic health. The Precision Peptide Genetic Test identifies genetic variants affecting appetite regulation and insulin sensitivity that influence your personal weight loss trajectory.

Can I stay on a lower semaglutide dose long-term without increasing?

Yes—many patients achieve stable, sustained weight loss at doses below 2 mg weekly without needing further escalation. PlexusDx Microdose GLP-1 Protocol ($129/mo) specifically supports patients seeking gentler, sustained therapy rather than maximum-dose acceleration. Genetic testing through the Precision Peptide panel can identify whether your biology predicts success at lower maintenance doses.

What happens if my semaglutide dose needs to increase—will my PlexusDx price change?

No. PlexusDx pricing is flat per compound regardless of dose level—your compounded semaglutide injection stays at $149 monthly whether you're at 0.25 mg or 2.4 mg. This pricing structure ensures predictable, transparent costs throughout your entire treatment journey as your dose escalates.

How does the Precision Peptide Genetic Test help determine my ideal semaglutide dose?

The Precision Peptide Genetic Test ($99 add-on) identifies your genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 additional metabolic pathways across 49 peptides, revealing whether you have genetic predispositions toward strong or modest GLP-1 receptor responsiveness. Patients with certain FTO variants may experience higher appetite drive requiring higher doses, while those with sensitive GIPR signaling may achieve results at lower doses. This genetic insight lets your provider design dosing strategy aligned with your biology from day one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves